Zobrazeno 1 - 10 of 52 pro vyhledávání: '"MacDowell KS"'
1
Analysis of Molecular Networks in the Cerebellum in Chronic Schizophrenia: Modulation by Early Postnatal Life Stressors in Murine Models
Autor: Vera-Montecinos A, Rodríguez-Mias R, MacDowell KS, García-Bueno B, Bris ÁG, Caso JR, Villén J, Ramos B
Publikováno v: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Despite the growing importance of the cerebellum as a region highly vulnerable to accumulating molecular errors in schizophrenia, limited information is available regarding altered molecular networks with potential therapeutic targets. To identify al
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::61479c145c5a9f3474faba3dbaf337a1
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20111
Zobrazit plný text záznamu
2
Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology
Autor: Afia AB, Vila È, MacDowell KS, Ormazabal-Herrero A, Leza JC, Haro JM, Artuch-Iriberri R, Ramos B, Garcia-Bueno B
Publikováno v: JOURNAL OF NEUROINFLAMMATION
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
BACKGROUND: The cortico-cerebellar-thalamic-cortical circuit has been implicated in the emergence of psychotic symptoms in schizophrenia (SZ). The kynurenine pathway (KP) has been linked to alterations in glutamatergic and monoaminergic neurotransmis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::2abf511f2caeb857abdc4cbd90652741
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20064
Zobrazit plný text záznamu
3
Differential regulation of the TLR4 signalling pathway in post-mortem prefrontal cortex and cerebellum in chronic schizophrenia: Relationship with SP transcription factors
Autor: MacDowell KS, Pinacho R, Leza JC, Costa Escolà J, Ramos B, García-Bueno B
Publikováno v: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Alterations in innate immunity may underlie the pathophysiology of schizophrenia (SZ). Toll-like receptor-4 (TLR4) is a master element of innate immunity. The specificity proteins (SPs), transcription factors recently implicated in SZ, are putative r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4e6a1bfbfd6b75b4a7d90ebbc20c866d
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12874
Zobrazit plný text záznamu
4
Akademický článek
Paliperidone Prevents Brain Toll-Like Receptor 4 Pathway Activation and Neuroinflammation in Rat Models of Acute and Chronic Restraint Stress.
Autor: MacDowell, KS, Caso, JR, Martín-Hernández, D, Madrigal, JL, Leza, JC, García-Bueno, B
Publikováno v: International Journal of Neuropsychopharmacology; Feb2015, Vol. 18 Issue 3, p1-1, 1p
Zobrazit plný text záznamu
5
Akademický článek
Inflammatory profiles in women with eating disorder: Linking inflammatory biomarkers to clinical phenotypes.
Autor: Díaz-Marsá M; Network Center for Biomedical Research in Mental Health, Institute of Health 'Carlos III' (CIBERSAM, ISCIII), Madrid, Spain; Department of Legal Medicine, Psychiatry, and Pathology, School of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain; IIS Hospital Clínico San Carlos, Madrid, Spain., Ayad-Ahmed W; IIS Hospital Clínico San Carlos, Madrid, Spain., López-Villatoro JM; Department of Legal Medicine, Psychiatry, and Pathology, School of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain; IIS Hospital Clínico San Carlos, Madrid, Spain. Electronic address: jolope09@ucm.es., Fernández-Rodrigues V; IIS Hospital Clínico San Carlos, Madrid, Spain; Faculty of Psychology, UCM, Spain., Ruiz-Guerrero F; Hospital Universitario Marqués de Valdecilla, Santander, Spain; Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain., Gómez Del Barrio A; Network Center for Biomedical Research in Mental Health, Institute of Health 'Carlos III' (CIBERSAM, ISCIII), Madrid, Spain; Hospital Universitario Marqués de Valdecilla, Santander, Spain; Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain., Beato-Fernández L; Hospital General Universitario de Ciudad Real, Spain., Polo-Montes F; Hospital General Universitario de Ciudad Real, Spain., León-Velasco M; Hospital General Universitario de Ciudad Real, Spain., Torre-Luque A; Network Center for Biomedical Research in Mental Health, Institute of Health 'Carlos III' (CIBERSAM, ISCIII), Madrid, Spain; Department of Legal Medicine, Psychiatry, and Pathology, School of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain., Carrasco JL; Network Center for Biomedical Research in Mental Health, Institute of Health 'Carlos III' (CIBERSAM, ISCIII), Madrid, Spain; Department of Legal Medicine, Psychiatry, and Pathology, School of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain; IIS Hospital Clínico San Carlos, Madrid, Spain., Caso JR; Network Center for Biomedical Research in Mental Health, Institute of Health 'Carlos III' (CIBERSAM, ISCIII), Madrid, Spain; Department of Pharmacology and Toxicology, School of Medicine, UCM, Madrid, Spain; IIS Hospital 12 de Octubre (Imas12), IUIN-UCM, Madrid, Spain., MacDowell KS; Network Center for Biomedical Research in Mental Health, Institute of Health 'Carlos III' (CIBERSAM, ISCIII), Madrid, Spain; Department of Pharmacology and Toxicology, School of Medicine, UCM, Madrid, Spain; IIS Hospital 12 de Octubre (Imas12), IUIN-UCM, Madrid, Spain., Leza JC; Network Center for Biomedical Research in Mental Health, Institute of Health 'Carlos III' (CIBERSAM, ISCIII), Madrid, Spain; Department of Pharmacology and Toxicology, School of Medicine, UCM, Madrid, Spain; IIS Hospital 12 de Octubre (Imas12), IUIN-UCM, Madrid, Spain.
Publikováno v: Psychoneuroendocrinology [Psychoneuroendocrinology] 2024 Apr; Vol. 162, pp. 106956. Date of Electronic Publication: 2024 Jan 03.
Zobrazit plný text záznamu
6
Akademický článek
Transdiagnostic inflammatory and oxidative biomarkers with predictive capacity of self-injurious behavior in impulsive and unstable disorders.
Autor: López-Villatoro JM; Institute of Health Research, Hospital Clínico San Carlos (IdISSC), Madrid, Spain; Department of Psychiatry and Medical Psychology, Faculty of Medicine, UCM, Madrid, Spain. Electronic address: jolope09@ucm.es., De la Torre-Luque A; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Madrid, Spain; Department of Psychiatry and Medical Psychology, Faculty of Medicine, UCM, Madrid, Spain., MacDowell KS; Department of Pharmacology and Toxicology, Faculty of Medicine, University Complutense de Madrid (UCM), Institute of Health Research Hospital 12 de Octubre (imas12), University Institute of Research in Neurochemistry UCM, Madrid, Spain; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Madrid, Spain., Galvez-Merlin A; Department of Psychiatry and Medical Psychology, Faculty of Medicine, UCM, Madrid, Spain., Gómez Del Barrio A; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Madrid, Spain; Marqués de Valdecilla University Hospital, Eating Disorders Unit, Department of Psychiatry, Santander, Spain; Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain., Beato-Fernández L; General Hospital of Ciudad Real, Ciudad Real, Spain., Ruiz-Guerrero F; Marqués de Valdecilla University Hospital, Eating Disorders Unit, Department of Psychiatry, Santander, Spain; Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain., Mola-Cardenes P; Institute of Health Research, Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Polo-Montes F; General Hospital of Ciudad Real, Ciudad Real, Spain., León-Velasco M; General Hospital of Ciudad Real, Ciudad Real, Spain., Castro-Fuentes L; Marqués de Valdecilla University Hospital, Eating Disorders Unit, Department of Psychiatry, Santander, Spain., Leza JC; Department of Pharmacology and Toxicology, Faculty of Medicine, University Complutense de Madrid (UCM), Institute of Health Research Hospital 12 de Octubre (imas12), University Institute of Research in Neurochemistry UCM, Madrid, Spain; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Madrid, Spain., Carrasco JL; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Madrid, Spain; Department of Psychiatry and Medical Psychology, Faculty of Medicine, UCM, Madrid, Spain., Díaz-Marsá M; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Madrid, Spain; Department of Psychiatry and Medical Psychology, Faculty of Medicine, UCM, Madrid, Spain.
Publikováno v: Progress in neuro-psychopharmacology & biological psychiatry [Prog Neuropsychopharmacol Biol Psychiatry] 2024 Mar 02; Vol. 130, pp. 110927. Date of Electronic Publication: 2023 Dec 25.
Zobrazit plný text záznamu
7
Akademický článek
Decreased oxytocin plasma levels and oxytocin receptor expression associated with aggressive behavior in aggressive-impulsive disorders.
Autor: Diaz-Marsá M; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Spain; Department of Psychiatry and Medical Psychology, Faculty of Medicine, UCM, Spain., López-Villatoro JM; Institute of Health Research, Hospital Clínico San Carlos (IdISSC), Spain; Department of Psychiatry and Medical Psychology, Faculty of Medicine, UCM, Spain. Electronic address: jolope09@ucm.es., De la Torre-Luque A; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Spain; Department of Psychiatry and Medical Psychology, Faculty of Medicine, UCM, Spain., MacDowell KS; Department of Pharmacology and Toxicology, Faculty of Medicine, University Complutense de Madrid (UCM), Institute of Health Research Hospital 12 de Octubre (imas12), University Institute of Research in Neurochemistry UCM, Spain; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Spain., Galvez-Merlin A; Department of Psychiatry and Medical Psychology, Faculty of Medicine, UCM, Spain., Gómez Del Barrio A; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Spain; Marqués de Valdecilla University Hospital, Eating Disorders Unit, Department of Psychiatry, Santander, Spain; Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain., Ruiz-Guerrero F; Marqués de Valdecilla University Hospital, Eating Disorders Unit, Department of Psychiatry, Santander, Spain; Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain., Beato-Fernández L; General Hospital of Ciudad Real. Ciudad Real, Spain., Polo-Montes F; General Hospital of Ciudad Real. Ciudad Real, Spain., León-Velasco M; General Hospital of Ciudad Real. Ciudad Real, Spain., Martín-Hernández D; Department of Pharmacology and Toxicology, Faculty of Medicine, University Complutense de Madrid (UCM), Institute of Health Research Hospital 12 de Octubre (imas12), University Institute of Research in Neurochemistry UCM, Spain; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Spain., Carrasco-Diaz A; Francisco de Vitoria University, Madrid, Spain., Leza JC; Department of Pharmacology and Toxicology, Faculty of Medicine, University Complutense de Madrid (UCM), Institute of Health Research Hospital 12 de Octubre (imas12), University Institute of Research in Neurochemistry UCM, Spain; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Spain., Carrasco JL; Biomedical Research Networking Consortium for Mental Health (CIBERSAM), Spain; Department of Psychiatry and Medical Psychology, Faculty of Medicine, UCM, Spain.
Publikováno v: Journal of psychiatric research [J Psychiatr Res] 2024 Feb; Vol. 170, pp. 200-206. Date of Electronic Publication: 2023 Dec 23.
Zobrazit plný text záznamu
8
Akademický článek
N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia.
Autor: Romero-Miguel D; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, 28007, Spain.; Department of Bioengineering, Universidad Carlos III de Madrid, Leganés (Madrid), 28911, Spain., Casquero-Veiga M; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, 28007, Spain.; Instituto de Investigación Sanitaria Fundación Jiménez Díaz, IIS-FJD, 28040, Madrid, Spain.; Cardiovascular Imaging and Population Studies, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029, Madrid, Spain., Lamanna-Rama N; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, 28007, Spain.; Department of Bioengineering, Universidad Carlos III de Madrid, Leganés (Madrid), 28911, Spain., Torres-Sánchez S; CIBER de Salud Mental (CIBERSAM), Madrid, 28029, Spain.; Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, Universidad de Cádiz, Cádiz, 11003, Spain.; Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz (INiBICA), Hospital Universitario Puerta del Mar, Cádiz, 11009, Spain., MacDowell KS; CIBER de Salud Mental (CIBERSAM), Madrid, 28029, Spain.; Department of Pharmacology & Toxicology, School of Medicine, Universidad Complutense (UCM), IIS Imas12, IUIN, Madrid, 28040, Spain., García-Partida JA; Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, Universidad de Cádiz, Cádiz, 11003, Spain.; Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz (INiBICA), Hospital Universitario Puerta del Mar, Cádiz, 11009, Spain., Santa-Marta C; Department of Mathematical and Fluids Physics, UNED, Madrid, 28040, Spain., Berrocoso E; CIBER de Salud Mental (CIBERSAM), Madrid, 28029, Spain.; Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, Universidad de Cádiz, Cádiz, 11003, Spain.; Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz (INiBICA), Hospital Universitario Puerta del Mar, Cádiz, 11009, Spain., Leza JC; CIBER de Salud Mental (CIBERSAM), Madrid, 28029, Spain.; Department of Pharmacology & Toxicology, School of Medicine, Universidad Complutense (UCM), IIS Imas12, IUIN, Madrid, 28040, Spain., Desco M; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, 28007, Spain. desco@hggm.es.; Department of Bioengineering, Universidad Carlos III de Madrid, Leganés (Madrid), 28911, Spain. desco@hggm.es.; CIBER de Salud Mental (CIBERSAM), Madrid, 28029, Spain. desco@hggm.es.; Advanced Imaging Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, 28029, Spain. desco@hggm.es., Soto-Montenegro ML; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, 28007, Spain. marisa@hggm.es.; CIBER de Salud Mental (CIBERSAM), Madrid, 28029, Spain. marisa@hggm.es.; Grupo de Fisiopatología y Farmacología del Sistema Digestivo de la Universidad Rey Juan Carlos (NeuGut), Alcorcón (Madrid), 28922, Spain. marisa@hggm.es.
Publikováno v: Translational psychiatry [Transl Psychiatry] 2024 Jan 08; Vol. 14 (1), pp. 14. Date of Electronic Publication: 2024 Jan 08.
Zobrazit plný text záznamu
9
Akademický článek
THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation.
Autor: Lamanna-Rama N; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Departamento de Bioingeniería, Universidad Carlos III de Madrid, Leganés (Madrid) 28911, Spain., Romero-Miguel D; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Casquero-Veiga M; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., MacDowell KS; CIBER de Salud Mental (CIBERSAM), Madrid, Spain; Department of Pharmacology & Toxicology, School of Medicine, Universidad Complutense (UCM), IIS Imas12, IUIN, 28040 - Madrid, Spain., Santa-Marta C; Departamento de Física Matemática y de Fluidos, UNED, Madrid, Spain., Torres-Sánchez S; CIBER de Salud Mental (CIBERSAM), Madrid, Spain; Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, Universidad de Cádiz, Spain; Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz, INiBICA, Hospital Universitario Puerta del Mar, Cádiz, Spain., Berrocoso E; CIBER de Salud Mental (CIBERSAM), Madrid, Spain; Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, Universidad de Cádiz, Spain; Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz, INiBICA, Hospital Universitario Puerta del Mar, Cádiz, Spain., Leza JC; CIBER de Salud Mental (CIBERSAM), Madrid, Spain; Department of Pharmacology & Toxicology, School of Medicine, Universidad Complutense (UCM), IIS Imas12, IUIN, 28040 - Madrid, Spain., Desco M; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Departamento de Bioingeniería, Universidad Carlos III de Madrid, Leganés (Madrid) 28911, Spain; CIBER de Salud Mental (CIBERSAM), Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. Electronic address: desco@hggm.es., Soto-Montenegro ML; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; CIBER de Salud Mental (CIBERSAM), Madrid, Spain; High Performance Research Group in Physiopathology and Pharmacology of the Digestive System (NeuGut-URJC), URJC, Alcorcón, Spain. Electronic address: marisa@hggm.es.
Publikováno v: Psychiatry research [Psychiatry Res] 2024 Jan; Vol. 331, pp. 115643. Date of Electronic Publication: 2023 Nov 27.
Zobrazit plný text záznamu
10
Akademický článek
Differential regulation of innate immune system in frontal cortex and hippocampus in a "double-hit" neurodevelopmental model in rats.
Autor: Bris ÁG; Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid. Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM, ISCIII). Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12) e Instituto Universitario de Investigación en Neuroquímica (IUIN), Spain., MacDowell KS; Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid. Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM, ISCIII). Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12) e Instituto Universitario de Investigación en Neuroquímica (IUIN), Spain., Ulecia-Morón C; Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid. Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM, ISCIII). Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12) e Instituto Universitario de Investigación en Neuroquímica (IUIN), Spain., Martín-Hernández D; Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid. Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM, ISCIII). Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12) e Instituto Universitario de Investigación en Neuroquímica (IUIN), Spain., Moreno B; Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid. Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM, ISCIII). Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12) e Instituto Universitario de Investigación en Neuroquímica (IUIN), Spain., Madrigal JLM; Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid. Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM, ISCIII). Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12) e Instituto Universitario de Investigación en Neuroquímica (IUIN), Spain., García-Bueno B; Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid. Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM, ISCIII). Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12) e Instituto Universitario de Investigación en Neuroquímica (IUIN), Spain., Caso JR; Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid. Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM, ISCIII). Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12) e Instituto Universitario de Investigación en Neuroquímica (IUIN), Spain., Leza JC; Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid. Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM, ISCIII). Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12) e Instituto Universitario de Investigación en Neuroquímica (IUIN), Spain. Electronic address: jcleza@med.ucm.es.
Publikováno v: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2024 Jan; Vol. 21 (1), pp. e00300. Date of Electronic Publication: 2023 Dec 19.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje